Jerome Dvonch
Director of Finance/CFO at SONOMA PHARMACEUTICALS, INC.
Net worth: 14 164 $ as of 30/05/2024
Profile
Jerome J.
Dvonch is currently the Chief Financial Officer at Sonoma Pharmaceuticals, Inc. He previously held positions such as Associate Director-Financial Planning & Analysis at Protein Design Labs, Inc. from 2004 to 2005, Chief Accounting Officer & Finance Director at NeoGenomics, Inc. in 2011, Associate Director-Financial Analysis & Reporting at Exelixis, Inc. from 2000 to 2004, Finance Director at NeoGenomics Laboratories, Inc. from 2005 to 2015, and Manager-Business Analysis at PharmChem, Inc. He also served as the Controller and SVP-Finance & Accounting at Spine Center Atlanta.
Mr. Dvonch holds an MBA from Rochester Christian University and an undergraduate degree from Niagara University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 19/06/2024 | 69,091 ( 0.44% ) | 14 164 $ | 30/05/2024 |
Jerome Dvonch active positions
| Companies | Position | Start |
|---|---|---|
| SONOMA PHARMACEUTICALS, INC. | Director of Finance/CFO | 07/09/2020 |
Former positions of Jerome Dvonch
| Companies | Position | End |
|---|---|---|
| SONOMA PHARMACEUTICALS, INC. | Director of Finance/CFO | 02/10/2022 |
NeoGenomics Laboratories, Inc.
 NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services NeoGenomics Laboratories, Inc. operates as a cancer diagnostics and pharma services company. It serves oncologists, pathologists, pharmaceutical companies, academic centers, and others with diagnostic, prognostic and predictive testing. The company was founded in 2002 and is headquartered in Fort Myers, FL. | Director of Finance/CFO | 30/06/2015 |
Protein Design Labs, Inc.
 Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. | Corporate Officer/Principal | 30/06/2005 |
| EXELIXIS, INC. | Corporate Officer/Principal | 31/05/2004 |
| Spine Center Atlanta | Comptroller/Controller/Auditor | - |
Training of Jerome Dvonch
| Rochester Christian University | Masters Business Admin |
| Niagara University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| PHARMCHEM, INC. | Health Services |
| NEOGENOMICS, INC. | Health Services |
| EXELIXIS, INC. | Health Technology |
| SONOMA PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. | Health Technology |
NeoGenomics Laboratories, Inc.
NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services NeoGenomics Laboratories, Inc. operates as a cancer diagnostics and pharma services company. It serves oncologists, pathologists, pharmaceutical companies, academic centers, and others with diagnostic, prognostic and predictive testing. The company was founded in 2002 and is headquartered in Fort Myers, FL. | Health Services |
| Spine Center Atlanta |
- Stock Market
- Insiders
- Jerome Dvonch
